Literature DB >> 26671425

Prevalence of various comorbidities among veterans with chronic kidney disease and its comparison with other datasets.

Nilang Patel1,2, Mojgan Golzy3, Neha Nainani4, Nader D Nader5,6, Randolph L Carter3, James W Lohr7,8, Pradeep Arora8,9.   

Abstract

Chronic kidney disease (CKD) has a complicated interrelationship with various comorbidities. The purpose of this study was to describe the prevalence of various comorbidities among veterans with CKD and compare it with other datasets like Kidney Early Evaluation Program (KEEP), National Health and Nutrition Examination Survey (NHANES) and Medicare. Patients who had at least one outpatient visit in year 2007 (1 January 2007 to 31 December 2007) were included in the study (n =  75,787). Glomerular filtration rate (eGFR) was estimated by the Modification of Diet in Renal Disease (MDRD) study equation. CKD prevalence was calculated based on one or two serum creatinine values at least 3 months apart. Demographic data were obtained including age, gender, race, weight, height and body mass index (BMI). The prevalence of various comorbidities was also collected based on ICD 9 codes from the problem list. The prevalence of CKD among veterans was 47.3%, much higher than estimated in the US population. Patients with CKD were more likely to have any vascular disease (36.89% vs. 14.87%), diabetes (34.18% vs. 17.83%), hypertension (86.65% vs. 57.56%), and cancer (18.69% vs. 9.23%). Irrespective of age, the prevalence of vascular disease was much higher among veterans with CKD. The prevalence of coronary artery disease, peripheral vascular disease, and cancer was much higher among elderly veterans with CKD as compared to other datasets. CKD is a growing endemic associated with a high frequency of concomitant chronic illnesses. Public health resources should be applied for early recognition and risk modification of CKD.

Entities:  

Keywords:  Chronic kidney disease; comorbidities; epidemiology; prevalence; vascular disease; veterans

Mesh:

Year:  2015        PMID: 26671425     DOI: 10.3109/0886022X.2015.1117924

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  8 in total

1.  Standardizing Care Coordination Within the Department of Veterans Affairs.

Authors:  Clinton L Greenstone; Jennifer Peppiatt; Kristin Cunningham; Christina Hosenfeld; Michelle Lucatorto; Michael Rubin; Adrienne Weede
Journal:  J Gen Intern Med       Date:  2019-05       Impact factor: 5.128

2.  Optimizing the use of adjuvant chemotherapy in non-small cell lung cancer patients with comorbidities.

Authors:  Stacyann Bailey; Qian Wang; Chung Yin Kong; Kimberly Stone; Rajwanth Veluswamy; Susan E Bates; Cardinale B Smith; Juan P Wisnivesky; Keith Sigel
Journal:  Curr Probl Cancer       Date:  2022-05-21       Impact factor: 2.367

3.  Impact of sustained virologic response on chronic kidney disease progression in hepatitis C.

Authors:  Elizabeth S Aby; Tien S Dong; Jenna Kawamoto; Joseph R Pisegna; Jihane N Benhammou
Journal:  World J Hepatol       Date:  2017-12-28

4.  Multimorbidity of four cardiometabolic and chronic pulmonary disease groups: prevalence and attributable fraction in US adults, 2007-2012.

Authors:  Lisa R Staimez; Melissa Y Wei; Min Kim; K M Venkat Narayan; Sharon H Saydah
Journal:  J Comorb       Date:  2017-03-13

5.  Physical Therapy Considerations for Chronic Kidney Disease and Secondary Sarcopenia.

Authors:  Haniel J Hernandez; Gideon Obamwonyi; Michael O Harris-Love
Journal:  J Funct Morphol Kinesiol       Date:  2018-01-05

6.  Sodium-glucose cotransporter 2 inhibitors for diabetic kidney disease: a primer for deprescribing.

Authors:  Jiahua Li; Christopher O Fagbote; Min Zhuo; Chelsea E Hawley; Julie M Paik
Journal:  Clin Kidney J       Date:  2019-08-14

7.  Prevalence of chronic kidney disease in the community using data from OxRen: a UK population-based cohort study.

Authors:  Jennifer A Hirst; Nathan Hill; Chris A O'Callaghan; Daniel Lasserson; Richard J McManus; Emma Ogburn; José M Ordóñez Mena; Brian Shine; Clare J Taylor; Maria Dla Vazquez-Montes; Yaling Yang; Fd Richard Hobbs
Journal:  Br J Gen Pract       Date:  2020-03-26       Impact factor: 5.386

8.  Ambulatory Blood Pressure Phenotypes in Adults Taking Antihypertensive Medication with and without CKD.

Authors:  Stanford E Mwasongwe; Rikki M Tanner; Bharat Poudel; Daniel N Pugliese; Bessie A Young; Marwah Abdalla; Solomon K Musani; Orlando M Gutiérrez; Adolfo Correa; Daichi Shimbo; Paul Muntner
Journal:  Clin J Am Soc Nephrol       Date:  2020-03-26       Impact factor: 8.237

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.